EichorEICHOR
Condition: Congenital Cytomegalovirus Infection Synced from ClinicalTrials.gov · August 03, 2026

Recruiting studies: Congenital Cytomegalovirus Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Cytomegalovirus (CMV) Transmission and Immune Tracking (TransmIT) Study
Phase N/A · 1 location(s) · University of Massachusetts, Worcester · NCT06522880Overview of Targeted Screening for Congenital Infection Guided by Neonatal Hearing Screening
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT07335874Evaluation of Software for Interpreting Virological Results Indicated for the Diagnosis of Cytomegalovirus (CMV) Infecti
Phase N/A · 3 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06694428Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Versus Valaciclovir
Phase 3 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05446571Long-Term Outcomes of Children With Congenital CMV in New York State
Phase N/A · 1 location(s) · Stony Brook University · NCT06226558Immunological and Virological Prognostic Markers of Human Cytomegalovirus (HCMV) Congenital Infection in Pregnant Women
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07477925Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)
Phase 2 · 9 location(s) · New York Medical College · NCT03266640Protein Biomarkers and Host RNA Expression Profiles in Congenital Cytomegalovirus Infection
Phase N/A · 2 location(s) · Rigshospitalet, Denmark · NCT07635368CMV CTLs in Neonates With CMV Infection
Phase 2 · 4 location(s) · New York Medical College · NCT05564598Observational Study of the Management of Infants With Congenital CMV
Phase N/A · 1 location(s) · St George's, University of London · NCT05855889Ganciclovir Resistant/Refractory Cytomegalovirus Infection in SOT Recipients and HSCT Patients
Phase N/A · 23 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT05234723
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.